- Quest Diagnostics (NYSE:DGX): Q2 Non-GAAP EPS of $3.18 beats by $0.32; GAAP EPS of $4.96 beats by $1.62.
- Revenue of $2.55B (+39.3% Y/Y) beats by $170M.
- Revenue of $9.54B-$9.79B vs. $9.43B consensus.
- Adj. EPS of $10.65-$11.35 vs. $11.11 consensus. GAAP EPS of $11.48-$12.18.
- Press Release
Quest Diagnostics EPS beats by $0.32, beats on revenue
Recommended For You
About DGX Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
DGX | - | - |
Quest Diagnostics Incorporated |